Terminated PHASE3 INTERVENTIONAL NCT00017277

Radiation Therapy With or Without Epoetin Alfa in Treating Patients With Head and Neck Cancer

A Phase III Double-Blind, Randomized, Placebo-Controlled Study of Erythropoietin When Used as an Adjuvant to Radiation Therapy in Patients With Head and Neck Squamous Cell Carcinoma

Sponsor: Charite University, Berlin, Germany

Conditions Head and Neck Cancer

Interventions epoetin alfa radiation therapy

Updated 6 times since 2017 Last updated: Sep 20, 2012 Started: Mar 31, 2001 Primary completion: Apr 30, 2003

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

low accrual

Other terminated trials from Charite University, Berlin, Germany

See all terminations from Charite University, Berlin, Germany

Other Head and Neck Cancer trials with similar outcome

Browse all Head and Neck Cancer trials

This PHASE3 trial investigates Head and Neck Cancer and is currently terminated or withdrawn. Charite University, Berlin, Germany leads this study, which shows 6 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Terminated PHASE3
Sep 2024 — Sep 2025 [monthly]

Terminated PHASE3
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE3
Jan 2021 — Jul 2024 [monthly]

Terminated PHASE3
Jun 2018 — Jan 2021 [monthly]

Terminated PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Terminated PHASE3

First recorded

Mar 2001

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Charite University, Berlin, Germany
European Organisation for Research and Treatment of Cancer - EORTC
Groupe Oncologie Radiotherapie Tete et Cou
Grup per l'Estudi dels Limfomes de Catalunya i Balears
Radius Hungaricus Oncology Group
Trans Tasman Radiation Oncology Group

Data source: European Organisation for Research and Treatment of Cancer - EORTC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Antwerp, Belgium , Barcelona, Spain , Bellinzona, Switzerland , Berlin, Germany , Brussels (Bruxelles), Belgium , Glasgow, United Kingdom , Haifa, Israel , Haine-Saint-Paul, Belgium , Heerlen, Netherlands , Leuven, Belgium and 4 more locations